EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review

Delia Reurean-Pintilei iD, Anca Pantea Stoian iD, Claudia-Gabriela Potcovaru iD, Teodor Salmen iD, Delia Cinteză iD, Roxana-Adriana Stoica, Sandra Lazăr, Bogdan Timar

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25073889 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Delia Reurean-Pintilei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Medicine and Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Skin, Glycation End Products, Advanced. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM), due to its long-term hyperglycemia, leads to the accumulation of advanced glycation end-products (AGEs), especially in the vessel walls. Skin autofluorescence (SAF) is a non-invasive tool that measures AGEs. DM patients have a rich dietary source in AGEs, associated with high oxidative stress and long-term inflammation. AGEs represent a cardiovascular (CV) risk factor, and they are linked with CV events. Our objective was to assess whether SAF predicts future CV events (CVE) by examining its association with other CV risk factors in patients with type 2 DM (T2DM). Additionally, we assessed the strengths and limitations of SAF as a predictive tool for CVE. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology, we conducted a systematic review with CRD42024507397 protocol, focused on AGEs, T2DM, SAF, and CV risk. We identified seven studies from 2014 to 2024 that predominantly used the AGE Reader Diagnostic Optic tool. The collective number of patients involved is 8934, with an average age of 63. So, SAF is a valuable, non-invasive marker for evaluating CV risk in T2DM patients. It stands out as a CV risk factor associated independently with CVE. SAF levels are influenced by prolonged hyperglycemia, lifestyle, aging, and other chronic diseases such as depression, and it can be used as a predictive tool for CVE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesSkinGlycation End Products, AdvancedBiomarkersHumansRisk AssessmentHeart Disease Risk FactorsOptical ImagingRisk Factors

Stichwörter der Autor:innen

AGECV risk factorsSAFT2DM

Substanzen

Glycation End Products, AdvancedBiomarkers

Autor:innen und Institutionen

  • Doctoral School of Medicine and Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Centre for Molecular Research in Nephrology and Vascular Disease, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Department of Diabetes, Nutrition and Metabolic Diseases, Consultmed Medical Centre, 700544 Iasi, Romania.
  • Diabetes, Nutrition and Metabolic Diseases Department, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • 9th Department of Physical Medicine and Rehabilitation, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Doctoral School, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

ORCID-Profile: Delia Reurean-Pintilei, Anca Pantea Stoian, Claudia-Gabriela Potcovaru, Teodor Salmen, Delia Cinteză

Zitieren

APA

Reurean-Pintilei, D., Pantea Stoian, A., Potcovaru, C. G., Salmen, T., Cinteză, D., Stoica, R. A., Lazăr, S., & Timar, B. (2024). Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073889

Vancouver

Reurean-Pintilei D, Pantea Stoian A, Potcovaru CG, Salmen T, Cinteză D, Stoica RA, et al. Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073889

BibTeX
@article{ReureanPintilei2024,
  author = {Reurean-Pintilei, Delia and Pantea Stoian, Anca and Potcovaru, Claudia-Gabriela and Salmen, Teodor and Cinteză, Delia and Stoica, Roxana-Adriana and Lazăr, Sandra and Timar, Bogdan},
  title = {Skin Autofluorescence as a Potential Adjunctive Marker for Cardiovascular Risk Assessment in Type 2 Diabetes: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25073889}
}
Kostenlos starten →